Clinical Trial Update: JAKPOT (JAK Inhibitors and Predictors of Outcome in RheumaToid Arthritis) [NA]

View source ↗

Summary

This clinical trial update reports termination of NCT04084223 (JAKPOT), a study of JAK inhibitors and predictors of outcome in rheumatoid arthritis. The sponsor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• JAK inhibitors (Janus kinase inhibitors)

Snippet

Sponsor: University Hospital, Montpellier | Conditions: Rheumatoid Arthritis | NA | Status: TERMINATED